Emcure Pharmaceuticals Ltd. share price hit a record high on Wednesday amid a surge iN trading volumes. The total traded volume stood at 7.6 times the 30-day average, according to Bloomberg data, with the turnover on the NSE being over Rs 200 crore.
The stock hit Rs 1,769 on the NSE, rising 10%, compared to a 1.4% jump in the benchmark Nifty 50 and nearly 1% advance in the Nifty Pharma index.
Emcure Pharmaceuticals informed the stock exchanges that a meeting of its Board of Directors is scheduled to be held on Tuesday, May 5, 2026.
The Board will inter alia consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The Board will also consider the recommendation of the final dividend, if any, on the equity shares of the company for FY26.
Five analysts tracking the stock have a 'buy' rating on the stock and one suggests a 'hold', according to Bloomberg data. The average of 12-month price targets implies a 4% upside potential.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
